Scholars@Duke
Journal cover image

Why Negative Trials Are Positive for Heart Failure Patients.

Publication ,  Journal Article
O'Connor, CM
Published in: JACC Heart Fail
April 2016
Published version (DOI) Link to item

Duke Scholars

Christopher Michael O'Connor
Author Christopher Michael O'Connor Medicine, Clinical Pharmacology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

JACC Heart Fail

DOI

10.1016/j.jchf.2016.02.010

EISSN

2213-1787

Publication Date

April 2016

Volume

4

Issue

4

Start / End Page

329 / 330

Location

United States

Related Subject Headings

  • Humans
  • Heart Failure
  • Clinical Trials as Topic
  • Cardiotonic Agents
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
O’Connor, C. M. (2016). Why Negative Trials Are Positive for Heart Failure Patients. JACC Heart Fail, 4(4), 329–330. https://doi.org/10.1016/j.jchf.2016.02.010
O’Connor, Christopher M. “Why Negative Trials Are Positive for Heart Failure Patients.” JACC Heart Fail 4, no. 4 (April 2016): 329–30. https://doi.org/10.1016/j.jchf.2016.02.010.
O’Connor CM. Why Negative Trials Are Positive for Heart Failure Patients. JACC Heart Fail. 2016 Apr;4(4):329–30.
O’Connor, Christopher M. “Why Negative Trials Are Positive for Heart Failure Patients.” JACC Heart Fail, vol. 4, no. 4, Apr. 2016, pp. 329–30. Pubmed, doi:10.1016/j.jchf.2016.02.010.
O’Connor CM. Why Negative Trials Are Positive for Heart Failure Patients. JACC Heart Fail. 2016 Apr;4(4):329–330.
Journal cover image

Published In

JACC Heart Fail

DOI

10.1016/j.jchf.2016.02.010

EISSN

2213-1787

Publication Date

April 2016

Volume

4

Issue

4

Start / End Page

329 / 330

Location

United States

Related Subject Headings

  • Humans
  • Heart Failure
  • Clinical Trials as Topic
  • Cardiotonic Agents
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology